Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
BMC Infect Dis ; 21(1): 524, 2021 Jun 04.
Article in English | MEDLINE | ID: covidwho-1259187

ABSTRACT

BACKGROUND: With pandemic of coronavirus disease 2019 (COVID-19), human coronaviruses (HCoVs) have recently attached worldwide attention as essential pathogens in respiratory infection. HCoV-229E has been described as a rare cause of lower respiratory infection in immunocompetent adults. CASE PRESENTATION: We reported a 72-year-old man infected by HCoV-229E with rapid progression to acute respiratory distress syndrome, in conjunction with new onset atrial fibrillation, intensive care unit acquired weakness, and recurrent hospital acquired pneumonia. Clinical and radiological data were continuously collected. The absolute number of peripheral T cells and the level of complement components diminished initially and recovered after 2 months. The patient was successfully treated under intensive support care and discharged from the hospital after 3 months and followed. CONCLUSION: HCoV-229E might an essential causative agent of pulmonary inflammation and extensive lung damage. Supportive treatment was essential to HCoVs infection on account of a long duration of immunological recovery in critical HCoV-229E infection.


Subject(s)
Common Cold/diagnosis , Coronavirus 229E, Human , Coronavirus Infections/diagnosis , Pneumonia, Viral/diagnosis , Aged , Anti-Bacterial Agents/therapeutic use , Bronchoalveolar Lavage Fluid/virology , Common Cold/complications , Common Cold/virology , Coronavirus Infections/complications , Diabetes Mellitus , Healthcare-Associated Pneumonia/complications , Healthcare-Associated Pneumonia/drug therapy , High-Throughput Nucleotide Sequencing , Humans , Male , Pneumonia, Viral/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL